Resources

Type of publications
Regions
Diseases

5192 results found

2023 ∙ Li, Y. Liang, H. Ding, X. Cao, Y. Yang, D. Duan, Y.

Effectiveness of COVID-19 vaccine in children and adolescents with the Omicron variant: A systematic review and meta-analysis

  • Children
  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Lan, Z. Yan, J. Yang, Y. Tang, Z. Guo, X. Wu, Z. Jin, Q.

Effectiveness of COVID-19 vaccines among children and adolescents against SARS-CoV-2 variants: a meta-analysis

  • Children
  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Zhang, X. Xia, J. Jin, L. Wu, Y. Zheng, X. Cao, X. Meng, X. Li, J. Zhu, F.

Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Reifferscheid, L. Kiely, M. S. Lin, M. S. N. Libon, J. Kennedy, M. MacDonald, S. E.

Effectiveness of hospital-based strategies for improving childhood immunization coverage: A systematic review

  • Newborn
  • Children
  • Adolescents
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Zhang, J. Yang, W. Huang, F. Zhang, K.

Effectiveness of mRNA and viral-vector vaccines in epidemic period led by different SARS-CoV-2 variants: a systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Guo, K. Ni, P. Chang, S. Jin, Y. Duan, G. Zhang, R.

Effectiveness of mRNA vaccine against Omicron-related infections in the real world: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Del Riccio, M. Boccalini, S. Cosma, C. Vaccaro, G. Bonito, B. Zanella, B. Salvati, C. Giorgetti, D. Rigon, L. Biamonte, M. A. Monami, M. Bonanni, P. Bechini, A.

Effectiveness of pneumococcal vaccination on hospitalization and death in the adult and older adult diabetic population: a systematic review

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2023 ∙ Song, S. Madewell, Z. J. Liu, M. Longini, I. M. Yang, Y.

Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Ebrahim, S. Blose, N. Gloeck, N. Hohlfeld, A. Balakrishna, Y. Muloiwa, R. Gray, A. Parrish, A. Cohen, K. Lancaster, R. Kredo, T.

Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years: A systematic review and meta-analysis

  • Children
  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ Paul, P. El-Naas, A. Hamad, O. Salameh, M. A. Mhaimeed, N. Laswi, I. Abdelati, A. A. AlAnni, J. Khanjar, B. Al-Ali, D. Pillai, K. V. Elshafeey, A. Alroobi, H. Burney, Z. Mhaimeed, O. Bhatti, M. Sinha, P. Almasri, M. Aly, A. Bshesh, K. Chamseddine, R. Khalil, O. D'Souza, A. Shree, T. Mhaimeed, N. Yagan, L. Zakaria, D.

Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic review

  • All age groups
  • COVID-19
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...